• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Fibrinolysis in surgery patients. I. Possible relationship to a hemorrhagic diathesis.

作者信息

COON W W, HODGSON P E

出版信息

Surg Gynecol Obstet. 1952 Dec;95(6):717-24.

PMID:13005347
Abstract
摘要

相似文献

1
Fibrinolysis in surgery patients. I. Possible relationship to a hemorrhagic diathesis.外科手术患者的纤维蛋白溶解。I. 与出血素质的可能关系。
Surg Gynecol Obstet. 1952 Dec;95(6):717-24.
2
[INHIBITORS OF FIBRINOLYSIS IN THE TREATMENT OF HEMORRHAGE, HEMORRHAGIC DIATHESIS AND SOME OTHER PATHOLOGICAL CONDITIONS. I. SPECIFIC INHIBITORS OF FIBRINOLYSIS].[纤维蛋白溶解抑制剂在治疗出血、出血性素质及其他一些病理状况中的应用。I. 纤维蛋白溶解的特异性抑制剂]
Pol Arch Med Wewn. 1964;34:211-7.
3
[INHIBITORS OF FIBRINOLYSIS IN THE TREATMENT OF HEMORRHAGE, HEMORRHAGIC DIATHESIS AND SOME OTHER PATHOLOGICAL CONDITIONS. II. INHIBITORS OF PROTEOLYSIS AND FIBRINOLYSIS].[纤维蛋白溶解抑制剂在出血、出血性素质及其他一些病理状况治疗中的应用。II. 蛋白水解及纤维蛋白溶解抑制剂]
Pol Arch Med Wewn. 1964;34:351-5.
4
[Fibrinolysis and fibrinolytic hemorrhagic diatheses].
J Med Lyon. 1952 Oct 5;33(786):869-81.
5
[Fibrinolysis in pregnancy interrupted by Rh sensitivity; considerations on fibrinolytic hemorrhagic diathesis].[妊娠中的纤维蛋白溶解因Rh致敏而中断；关于纤维蛋白溶解性出血素质的思考]
Rev Hematol. 1952;7(1):60-71.
6
[2 cases of acute fibrinolysis treated with success by plasmin inhibitor. Survival. Secondary death].[2例急性纤溶用纤溶酶抑制剂成功治疗。存活。继发死亡]
Mem Acad Chir (Paris). 1961;87:155-61.
7
THE RELATIONSHIP of abnormal bleeding in surgical patients to administration of dextran, excesses of citrate and to fibrinolysis.手术患者异常出血与右旋糖酐的使用、柠檬酸盐过量以及纤维蛋白溶解的关系。
Surg Forum. 1956;6:88-121.
8
[Fibrinolytic activity of brain tumors and treatment of hemorrhagic diathesis].[脑肿瘤的纤溶活性与出血素质的治疗]
Schweiz Arch Neurol Neurochir Psychiatr. 1971;108(1):27-31.
9
Prostatic fibrinolysin; study of a case illustrating role in hemorrhagic diathesis of cancer of the prostate.前列腺纤维蛋白溶酶；一例说明其在前列腺癌出血素质中作用的病例研究。
Am J Med. 1953 Dec;15(6):875-84. doi: 10.1016/0002-9343(53)90178-8.
10
[Studies of the role of fibrinolysis in the pathogenesis of hemorrhagic diathesis].[纤溶在出血性素质发病机制中的作用研究]
Hemostase. 1961;1:237-41.

引用本文的文献

1
[On the problem of an antidote in internal thrombotherapy with fibrinolytics].[关于纤维蛋白溶解剂在内科血栓治疗中解毒剂的问题]
Blut. 1959 Dec;5:367-75. doi: 10.1007/BF01630279.
2
Hemorrhagic disorders occurring during and after surgical operation.手术期间及术后发生的出血性疾病。
Ann Surg. 1960 Jan;151(1):85-90.
3
Alterations in blood coagulation and hemostasis during extracorporeal circulation. II.体外循环期间血液凝固和止血的改变。II.
Can Med Assoc J. 1962 Oct 20;87(16):859-64.
4
Coagulation defects following extracorporeal circulation.体外循环后的凝血缺陷。
Ann Surg. 1963 Mar;157(3):317-26. doi: 10.1097/00000658-196303000-00001.
5
[Hyperfibrinolysis in prostatic carcinoma].[前列腺癌中的高纤维蛋白溶解]
Blut. 1962 Mar;8:22-8. doi: 10.1007/BF01570368.
6
Studies on spontaneous fibrinolytic activity in patients with cirrhosis of the liver and its inhibition by epsilon amino caproic acid.肝硬化患者自发纤溶活性及其受ε-氨基己酸抑制的研究。
Ann Surg. 1961 Mar;153(3):383-93. doi: 10.1097/00000658-196103000-00008.
7
The fibrinolytic enzyme system in normal, hemorrhagic and disease states.正常、出血及疾病状态下的纤溶酶系统
J Clin Invest. 1958 Jul;37(7):965-73. doi: 10.1172/JCI103692.
8
Coagulation disorders in combat casualties. I. Acute changes after wounding. II. Effects of massive transfusion. 3. Post-resuscitative changes.战斗伤员的凝血障碍。I. 受伤后的急性变化。II. 大量输血的影响。3. 复苏后的变化。
Ann Surg. 1969 Apr;169(4):455-82. doi: 10.1097/00000658-196904000-00001.
9
[Generalised plasmatic hypercoagulability and pulmonary hyaline membranes in the adult].[成人的全身性血浆高凝状态与肺透明膜]
Klin Wochenschr. 1971 Jan 15;49(2):71-81. doi: 10.1007/BF01497303.
10
Progress in disseminated intravascular coagulation. II.弥散性血管内凝血的研究进展。II.
Calif Med. 1969 Oct;111(4):279-90.